Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-19-000021
Filing Date
2019-01-07
Accepted
2019-01-07 18:49:13
Documents
1
Period of Report
2018-12-27

Document Format Files

Seq Description Document Type Size
1 form4-01072019_030157.html 4  
1 form4-01072019_030157.xml 4 11231
  Complete submission text file 0001415889-19-000021.txt   12679
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JDJ FAMILY OFFICE SERVICES P.O. BOX 962049 BOSTON MA 02196
Business Address
Ross Edmund Burke Jr. (Reporting) CIK: 0001682557 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 19514318